Home Who we are Financial Advisory Careers M&A and strategic advisory Capital markets advisory Transactions Contact Us

Nassau Street Transactions

$3,000,000 receivable factoring

Biotech & genomic company based out of New York. Strategic factoring of a large receivable to a private credit investor to fund working capital needs and improve liquidity

$300,000 bridge financing

$300,000 bridge financing secured for Bent Tree to support growth as they await the arrival of a large government receivable

$70,000,000 purchase order

A major U.S. electric utility, secured $70,000,000 in purchase order financing to support large-scale projects and enhance liquidity management.

$22,000,000 receivable factoring

One of the largest global food service and facilities management companies, strategically factored a large receivable to a private credit investor. This move helped the company fund working capital needs and support its expansion initiatives.

$8,000,000 Syndicated Loan

One of the largest manufacturers of food products in the middle east secured a syndicated loan to support the company's expansion plan and strengthen their balance sheet.

$5,000,000 receivable factoring

Nonprofit mental health organization pursued the factoring of a government receivable to a credit manager that purchased it at a slight discount within a two week period.

$2,500,000 bridge loan

Engineering & Construction company secured a $1,000,000 bridge loan facility which was further extended by $1,500,000 three months later. The capital was used to fund low income construction projects. The facility took two weeks to secure.

$1,500,000 bridge financing

Aletha is a healthcare company specializing in patented muscle-tension relief tools and mobility products. Secured a $1,500,000 bridge financing to support working capital needs.

Sha7en

$5,000,000 equity raise

Seed round for an EV charging station network operator in the Middle East. Round was placed primarily through institutional investors and early stage VCs.

Medical Device Manufacturer

$70,000,000 equity raise

Series B round placed with undisclosed group of HNWI for a medical device manufacturing company at a $300m pre-money valuation.

Sequence Ventures

$25,000,000 equity raise

Deep-tech venture capital firm raised USD 25 million through a private placement. The round was filled primarily with family offices and High-Net-Worth Investors.

Protein Product Manufacturer

$25,000,000 CAD equity raise

Series A round for a leading provider of protein products in North America. $25m round at a $100m pre-money valuation.

Process Technology Company

$50,000,000 equity raise

Series B round at a $175m pre money valuation for a process technology company.

Software and Big Data Company

$30,000,000 equity raise

Data analytics and software company that was ultimately acquired for $394m. $30,000,000 growth equity round placed with a large private equity investor ahead of its IPO.

Telecommunications Firm

$75,000,000 equity raise

Leading provider of internet and phone services raised $75,000,000 from a syndicate of ultra-high net worth investors and institutional investors.

Uptiq AI

$12,000,000 equity raise

Enterprise AI platform built for financial services raised a $12,000,000 equity round, with Nassau providing a supporting investor to the round. The round was filled with a mix of institutional and venture investors.

PranaQ

$1,000,000 equity raise

PranaQ, a digital healthcare company developing wearable medical devices and home sleep apnea diagnostics, successfully raised $1,000,000 in equity financing. Nassau sourced and provided the lead investor for the round, which included participation from institutional and strategic venture investors.

Integrated Medical Systems (IMS)

Negotiated all cash sale of the company to Eli Lilly during the drafting of the S-1 for its public offering. Amount not disclosed. This was a year after negotiating a strategic alliance with McKesson Corp for a significant investment in IMS.

Tomotherapy

$200+ million IPO. Avtech Ventures was a lead investor in the company and Gary was one of the lead directors holding positions on all committees of the board, helping shape the IPO.

Health & Media

Company sold to J&J. Avtech Ventures was the original investor and Gary was a lead director holding positions on all committees. He was instrumental in attracting the capital that fueled development of the company’s solution and led to its ultimate acquisition.

General Dynamics Electronic Systems

Exclusive advisor to GDE Systems’ divestiture of a stealth subsidiary.

WebSideStory

Exclusive advisor representing the sale of 10% of WebSideStory for $30 million to Summit Partners and TA Associates. WebSideStory was then acquired by Omniture and later acquired by Adobe for $1.8 billion.

Premier Medical Distribution

Exclusive advisor attracting two offers to buy the company, one from a leading strategic publicly traded healthcare company and the other from a large private equity firm.

Noma Therapy

Exclusive Advisor to Noma regarding strategic alternatives including a potential sale of the company.

Grand Central

Led VC firm that was shareholder in Grand Central that was sold to Google and became Google Voice.

Laser Power Corporation

Exclusive advisor to the company exploring strategic alternatives. Concluded that IPO was the preferred path, and then selected underwriters for company’s IPO.

Netclearance Systems

Exclusive advisor exploring strategic alternatives for this touchless payment system company.

Gnomegen

Exclusive advisor exploring strategic alternatives for this developer of advanced oncology diagnostic equipment company.

This website (the “Website”) is owned and operated by Nassau Street Partners. By accessing the Website and any pages thereof, you agree to be bound by our Terms of Service and Privacy Policy. The information contained herein is provided for informational purposes only and is not intended to influence any investment decision or be a recommendation for any investment, service, product, or other advice of any kind, and shall not constitute or imply an offer of any kind. Nassau Street Partners provides corporate and transaction advisory services exclusively to companies and institutional clients. It does not provide personalized investment advice to retail investors and is not registered as an investment adviser or broker-dealer. Services may not be available in all jurisdictions and are subject to applicable laws and regulatory approvals. Neither the SEC nor any federal or state securities commission or regulatory authority has recommended or approved any investment or the accuracy or completeness of any of the information or materials provided herein or through any references/links herein. There can be no assurance that any valuations provided by issuers are accurate or in agreement with market or industry valuations. We do not make any representations or warranties as to the accuracy of such information. 

Nassau Street Partners
40 WALL STREET, SUITE 2839,
NEW YORK, NY 10005
info@nassaustreetpartners.com